LGALS3 and acute lymphoblastic leukemia: For example, BMSC-Exo inhibited bortezomib mediated cell apoptosis in MM cells [103]; likewise, GAL3 Exo from stromal cells have been reported to activate the NFkB pathway in ALL cells, inducing an anti-apoptosis effect and drug resistance [109].